Pfizer Inc (NYSE:PFE)

43.95
Delayed Data
As of Sep 24
 -0.24 / -0.54%
Today’s Change
32.80
Today|||52-Week Range
51.86
+19.40%
Year-to-Date
Is It Too Late to Buy Moderna Stock?
7:00am / MotleyFool.com - Paid Partner Content
The Smartest Stocks to Buy With $1,000 Right Now
Sep 21 / MotleyFool.com - Paid Partner Content
Top Research Reports for Home Depot, salesforce & Pfizer
Sep 24 / Zacks.com - Paid Partner Content
Is Pfizer Stock a Buy After an FDA Panel Recommended Boosters for Ages 65 and Up?
Sep 21 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) Inks Deal to Enter Novel RNA Therapeutic Space
Sep 24 / Zacks.com - Paid Partner Content
Pfizer (PFE) Gains As Market Dips: What You Should Know
Sep 20 / Zacks.com - Paid Partner Content
Novavax (NVAX) Applies to WHO for COVID-19 Vaccine Listing
Sep 24 / Zacks.com - Paid Partner Content
Why Moderna Stock Is Falling Today
Sep 20 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Booster Dose Gets CDC Backing for Older Adults Only
Sep 24 / Zacks.com - Paid Partner Content
Big Pharma Stocks Hit Hard by Drug Price Proposals
Sep 20 / GuruFocus News - Paid Partner Content
7 Best ETFs of the First Nine Months of 2021
Sep 24 / Zacks.com - Paid Partner Content
Pfizer Gets a Small Boost From Vaccine Trial Announcement
Sep 20 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: PFE Booster Jab Gets FDA Nod, JNJ's New Data on COVID-19 Shot
Sep 24 / Zacks.com - Paid Partner Content
September Syndrome Deepens in Markets
Sep 20 / Zacks.com - Paid Partner Content
3 Things You Shouldn't Do if the Stock Market Crashes
Sep 24 / MotleyFool.com - Paid Partner Content
Contagion Fears Squeeze Pre-Market Futures
Sep 20 / Zacks.com - Paid Partner Content
Why Are Top Scientists Opposing COVID Boosters?
Sep 24 / MotleyFool.com - Paid Partner Content
Do These Words From Moderna's President Mean Trouble for Vaccine Makers?
Sep 20 / MotleyFool.com - Paid Partner Content
Nike, Costco Report Better Earnings than Expected
Sep 23 / Zacks.com - Paid Partner Content
FDA Panel Vetoes PFE/BNTX Third Jab for All, Vaccine Stocks Down
Sep 20 / Zacks.com - Paid Partner Content
US Indexes End With Gains Thursday
Sep 23 / GuruFocus News - Paid Partner Content
Is AbbVie a Bad News Buy?
Sep 19 / MotleyFool.com - Paid Partner Content
Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?
Sep 23 / Zacks.com - Paid Partner Content
Could Pfizer and Merck Be Big Winners With COVID Pills?
Sep 19 / MotleyFool.com - Paid Partner Content
Why BioNTech Thrashed the Market on Thursday
Sep 23 / MotleyFool.com - Paid Partner Content
Here's Why Moderna's Stock Could Crash Before the End of 2021
Sep 19 / MotleyFool.com - Paid Partner Content
Biogen Adds Another Drug to Its Stable of Biosimilars
Sep 23 / GuruFocus News - Paid Partner Content
Moderna's Bigger Catalyst: Full FDA Approval or Booster Authorization?
Sep 19 / MotleyFool.com - Paid Partner Content
Dynavax (DVAX) Gains on Clover's COVID-19 Vaccine Study Data
Sep 23 / Zacks.com - Paid Partner Content
Could This News Spark a Turnaround for Ocugen?
Sep 19 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Booster Dose Gets FDA Nod for High-Risk People
Sep 23 / Zacks.com - Paid Partner Content
AbbVie's Pain Is Sanofi's and Regeneron's Gain
Sep 18 / MotleyFool.com - Paid Partner Content
Why Moderna Stock Is Rising Today
Sep 22 / MotleyFool.com - Paid Partner Content
Why COVID Vaccine Stocks BioNTech, Moderna, and Novavax Are Sliding While Ocugen Is Rising
Sep 17 / MotleyFool.com - Paid Partner Content
J&J's (JNJ) New Data Shows COVID-19 Booster Ups Protection
Sep 22 / Zacks.com - Paid Partner Content
Axsome (AXSM) Begins Late-Stage Sleep Disorder Study on AXS-12
Sep 17 / Zacks.com - Paid Partner Content
Nektar (NKTR) Signs Deals With Pfizer, Merck KGaA for NKTR-255
Sep 22 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Files for Rinvoq in Ulcerative Colitis in US & EU
Sep 17 / Zacks.com - Paid Partner Content
Moderna's COVID Vaccine Could Be Better Than Pfizer's -- Here's Why Its Stock Isn't
Sep 22 / MotleyFool.com - Paid Partner Content
Is Moderna Winning on Vaccine Efficacy?
Sep 17 / MotleyFool.com - Paid Partner Content
Why Shares of Solid Biosciences Are Jumping Today
Sep 21 / MotleyFool.com - Paid Partner Content
3 Low-Risk Stocks for Conservative Investors
Sep 17 / MotleyFool.com - Paid Partner Content
2 Outperforming Biotech Stocks to Examine on Covid-19 Vaccine Updates
Sep 21 / GuruFocus News - Paid Partner Content
Why Moderna and BioNTech Topped the Market Today
Sep 16 / MotleyFool.com - Paid Partner Content
Pfizer's (PFE) COVID-19 Vaccine Successful in Children Study
Sep 21 / Zacks.com - Paid Partner Content
Pfizer, Moderna Support COVID Vaccine Booster Before FDA Meet
Sep 16 / Zacks.com - Paid Partner Content
Company News for Sep 21, 2021
Sep 21 / Zacks.com - Paid Partner Content
2 Pharma Stocks You Can Buy and Hold for the Next Decade
Sep 16 / MotleyFool.com - Paid Partner Content
Is Now the Time to Ditch Pharma Stocks?
Sep 21 / MotleyFool.com - Paid Partner Content
Should Pfizer Investors Worry About Tomorrow's FDA Meeting?
Sep 16 / MotleyFool.com - Paid Partner Content